Rheumatoid Arthritis Clinical Trial
Official title:
Biomarkers of Remission in Rheumatoid Arthritis (BioRRA)
Rheumatoid arthritis is a common condition affecting approximately 1% of the United Kingdom
populationÍž it is an autoimmune disease where the body's natural defences (the immune system)
attack the body itself resulting, most notably, in joint damage and arthritis. To help
prevent this, patients with rheumatoid arthritis need to take disease-modifying
anti-rheumatic drugs (DMARDs). As rheumatoid arthritis is a life-long condition, these drug
treatments are prescribed as long-term medications taken for many years.
With successful drug treatment, many patients are able to achieve an excellent control of
their disease and their arthritis can go in to remission. At present, there are no markers
which can reliably predict which of these patients can reduce their drug treatment, and hence
benefit from a lower risk of side effects and inconvenience, without an increase in their
arthritis activity.
We invite patients with stable rheumatoid arthritis to participate in this study conducted by
Newcastle upon Tyne Hospitals NHS Foundation Trust in collaboration with Newcastle University
and funded by the Wellcome Trust. Patients whose arthritis is confirmed as being in remission
will be able to stop their DMARD medication and be monitored for a period of 6 months.
Patients whose arthritis activity increases during this time will be able to restart their
DMARD medication, whereas those patients whose arthritis remains in remission will be able to
stay off DMARD medication.
The main aim of this study is to identify clinical, ultrasound and blood markers that can
predict which patients will remain in remission after stopping DMARD medication. If
identified, these markers could be a useful guide to doctors and patients in the future when
deciding whether to stop DMARD therapy.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |